Global Blood Therapeutics (GBT) Stock Highlights

68.49 | +0%

2022-12-24 02:57:33

Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.

Statistics

Range Today

68.49 68.49

Volume Today 0

Range 1 Year

21.65 73.02

Volume 1 Year 487.39M

Range 3 Year

21.65 87.54

Volume 3 Year 1.02B

Range 10 Year

12.24 87.54

Volume 10 Year 1.87B

Highlights

Market Capitalization 4.41B (mid)

Floating Shares 58.57M

Current Price 68.49

Price To Earnings -16.97

Price To Revenue 20.27

Price To Book 10.19

Earnings Per Share -4.04

Payout Ratio 0%

Performance

Latest 0%

1 Month +0.85%

3 Months +106.67%

6 Months +85.11%

1 Year +165.88%

3 Years +42.9%

5 Years +111.72%

10 Years +97.66%

Benchmarks

Market Capitalization

38 / 368

Gross Profits

32 / 278

Total Revenue

49 / 300

Total Rank

320 / 368

Free Cashflow

307 / 352

Performance 5 years

70 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.